InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Ansbert Gadicke, Director,TenPercentOwner, is a corporate insider tracked by InsiderTape across 4 companies. The public record shows 31 open-market SEC Form 4 transactions: 1 purchase worth $20.0M and 30 sales worth $23.1M, reported from Aug 11, 21 to Jan 12, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 26 | AKTSAktis Oncology, Inc. | BUY | 1.11M | $18.00 | $20.0M |
| May 22, 23 | TCRRTCR2 THERAPEUTICS INC. | SELL | 70.2K | $1.88 | $132K |
| Jan 5, 22 | ITOSiTeos Therapeutics, Inc. | SELL | 30.3K | $42.03 | $1.3M |
| Jan 4, 22 | ITOSiTeos Therapeutics, Inc. | SELL | 158.6K | $46.47 | $6.7M |
| Oct 14, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 45.7K | $27.30 | $1.2M |
| Oct 13, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 35.0K | $27.13 | $950K |
| Oct 12, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 14.3K | $27.09 | $386K |
| Oct 4, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 34.7K | $27.06 | $938K |
| Oct 1, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 11.5K | $27.00 | $310K |
| Sep 22, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 23.9K | $27.54 | $659K |
| Sep 21, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 32.9K | $27.47 | $903K |
| Sep 16, 21 | CGEMCullinan Oncology, Inc. | SELL | 3.1K | $29.06 | $91K |
| Sep 15, 21 | CGEMCullinan Oncology, Inc. | SELL | 6.4K | $29.16 | $187K |
| Sep 15, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 38.7K | $28.15 | $1.1M |
| Sep 14, 21 | CGEMCullinan Oncology, Inc. | SELL | 7.1K | $29.17 | $207K |
| Sep 14, 21 | ITOSiTeos Therapeutics, Inc. | SELL | 30.0K | $27.99 | $825K |
| Sep 13, 21 | CGEMCullinan Oncology, Inc. | SELL | 3.6K | $29.10 | $105K |
| Sep 10, 21 | CGEMCullinan Oncology, Inc. | SELL | 5.9K | $29.04 | $172K |
| Sep 9, 21 | CGEMCullinan Oncology, Inc. | SELL | 13.7K | $29.35 | $403K |
| Sep 8, 21 | CGEMCullinan Oncology, Inc. | SELL | 10.8K | $29.11 | $316K |
| Sep 7, 21 | CGEMCullinan Oncology, Inc. | SELL | 25.1K | $29.04 | $728K |
| Sep 3, 21 | CGEMCullinan Oncology, Inc. | SELL | 12.7K | $29.60 | $377K |
| Sep 2, 21 | CGEMCullinan Oncology, Inc. | SELL | 15.8K | $29.46 | $464K |
| Sep 1, 21 | CGEMCullinan Oncology, Inc. | SELL | 5.7K | $29.47 | $168K |
| Aug 31, 21 | CGEMCullinan Oncology, Inc. | SELL | 1.6K | $30.14 | $47K |
| Aug 30, 21 | CGEMCullinan Oncology, Inc. | SELL | 31.0K | $29.30 | $908K |
| Aug 27, 21 | CGEMCullinan Oncology, Inc. | SELL | 13.4K | $29.09 | $389K |
| Aug 25, 21 | CGEMCullinan Oncology, Inc. | SELL | 1.7K | $29.09 | $50K |
| Aug 24, 21 | CGEMCullinan Oncology, Inc. | SELL | 50.9K | $29.48 | $1.5M |
| Aug 23, 21 | CGEMCullinan Oncology, Inc. | SELL | 53.4K | $29.11 | $1.6M |
| Aug 11, 21 | CGEMCullinan Oncology, Inc. | SELL | 2.5K | $29.05 | $73K |